The state-of-the-art of atmospheric pressure plasma for transdermal drug delivery

Plasma-enhanced transdermal drug delivery(TDD) presents advantages over traditional methods,including painless application, minimal skin damage, and rapid recovery of permeability. To harness its clinical potential, factors related to plasma’s unique properties, such as reactive species and electric fields, must be carefully considered.This review provides a concise summary of conventional TDD methods and subsequently offers a comprehensive examination of the current state-of-the-art in plasma-enhanced TDD. This includes an analysis of the impact of plasma on HaCaT human keratinocyte cells, ex vivo/in vivo studies, and clinical research on plasma-assisted TDD. Moreover, the review explores the effects of plasma on skin physical characteristics such as microhole formation, transepidermal water loss(TEWL), molecular structure of the stratum corneum(SC), and skin resistance. Additionally, it discusses the involvement of various reactive agents in plasma-enhanced TDD, encompassing electric fields,charged particles, UV/VUV radiation, heat, and reactive species. Lastly, the review briefly addresses the temporal behavior of the skin after plasma treatment, safety considerations, and potential risks associated with plasma-enhanced TDD.

Current trends in management of hepatitis B virus reactivation in the biologic therapy era

Hepatitis B virus (HBV) reactivation represents an emerging cause of liver disease in patients undergoing treatment with biologic agents. In particular, the risk ofHBV reactivation is heightened by the use monoclonalantibodies, such as rituximab (anti-CD20) and alemtuzumab (anti-CD52) that cause profound and longlasting immunosuppression. Emerging data indicatethat HBV reactivation could also develop following theuse of other biologic agents, such as tumor necrosis factor (TNF)-α inhibitors. When HBV reactivation is di-agnosed, it is mandatory to suspend biologic treatmentand start antiviral agents immediately. However, preemptive antiviral therapy prior to monoclonal antibodyadministration is crucial in preventing HBV reactivationand its clinical consequences. Several lines of evidencehave shown that risk of HBV reactivation is greatlyreduced by the identifi cation of high-risk patients andthe use of prophylactic antiviral therapy. In this article, we discuss current trends in the management of HBV reactivation in immunosuppressed patients receiving biologic therapy, such as rituximab, alemtuzumab and TNF-α antagonists.

Refined Agent Model Using Shape-Based Grained Structure: Application to Membrane Molecules

Multi-agent model is well-known to suit design of complex systems. This paradigm allows describing autonomous entities to interact together directly or through their environment. It is specially adapted to design 3D simulations taking into account spatial constraints on agents. In this work, we have designed a multi-agent model which adds a feature to the classical representation of agent: a body, encapsulating a physical model of the agent. We have applied this model to lipids and proteins belonging to the inner mitochondrial membrane, a biological membrane. Information provided by atomic structures is available through international databases and has been used to design a shape-based grain model for the agent body. We selected a model with three grains per molecule in which each grain is characterized by a type determining how they interact together and consequently the agent behaviors. Lipids and two kinds of protein structures have been described within this model allowing us to simulate their organization in membranes.

Reactive Compatibilization of Short-Fiber Reinforced Poly(lactic acid)Biocomposites

Poor interfacial adhesion between biobased thermoplastics and natural fibers is recognized as a major drawback for biocomposites.To be applicable for the large-scale production,a simple method to handle is of importance.This work presented poly(lactic acid)(PLA)reinforced with short-fiber and three reactive agents including anhydride and epoxide groups were selected as compatibilizers.Biocomposites were prepared by one-step meltmixing methods.The influence of reactive agents on mechanical,dynamic mechanical properties and morphology of PLA biocomposites were investigated.Tensile strength and storage modulus of PLA biocomposites incorporated with epoxide-based reactive agent was increased 13.9%and 37.4%compared to non-compatibilized PLA biocomposite,which was higher than adding anhydride-based reactive agent.SEM micrographs and Molau test exhibited an improvement of interfacial fiber-matrix adhesion in the PLA biocomposites incorporated with epoxide-based reactive agent.FTIR revealed the chemical reaction between the fiber and PLA with the presence of epoxide-based reactive agents.